Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Spectral Medical Inc T.EDT

Alternate Symbol(s):  EDTXF

Spectral develops devices for unmet medical needs. Sepsis occurs in 1.7M Americans/year causing 250K deaths, often caused by endotoxin. Our devices measure and remove endotoxin from the bloodstream. An FDA confirmatory trial is underway. Dialco, a Spectral sub, offers SAMI, a novel instrument for renal replacement, cleared by FDA. Dialco is seeking FDA approval for DIMI a unique home dialysis enabler. These devices have large commercial potential


TSX:EDT - Post by User

Post by SouthernTierTomon Nov 29, 2021 4:25pm
259 Views
Post# 34177392

228.5K is the total vol., but only 33K showing in Toronto...

228.5K is the total vol., but only 33K showing in Toronto...If I were Canadien, I would write my congressman/lady and ask about financial transperancy.

In this day of fare and equitable treatment for all parties, why does Canada allow blatent disregard for retail shareholder's opportunity to play on a level pitch ( soccer / football jargon )  You'd need to be a carnie ( see ball in milkcan ) to see this activity as legal and fair.  Maybe that guy that acted as the first non-Brit to head the Bank of England should take the reigns up in Canada and sort you markets out.  I think it stinks and is pushing the boundaries of the law.  I can onlt think of one Carney to act and clean up this $tinky me$$.

Most ALL the BUYs today were pushed to the Dark Pools where people couldn't see them.  228.5K traded at an average of 22.9 CAD.  NO GREEN allowed to show up on the Canadien screens today....pity.

Sumphin $tinks Keefe...smells like olde, organized money...Hmmmm ; - )

Careful MM, Euphas 1 is a miss-noamer ( no, not a female garden decoration ) Euphas was a phase 2 trial and the Euphas 2 registry just a data-base exstension.  The PMX as a BP ( blood pressure / cardiac ) aid was the primary endpoint of the phase 2 Euphas, the 28 day mortality just a secondary endpoint that pleasantly surprised with a whopping 21% absolute benefit.  I'm sick of the KOL's whining about the FDA needing to STOP looking at 28 day mortality as the primary endpoint in RCT's ( randomized control trials )  CLEARLY, when applied during the Golden Shour, PMX is a most valid and worthy candidate to challenge this most stringent 28 day mortality test.

Always just my opinion ; - ) ....

Buena suerte,
Thomas a Tractor

<< Previous
Bullboard Posts
Next >>